Breast imaging readers' performance in the PERFORMS test-set based assessment scheme within the MyPeBS international randomised study
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Michalopoulou, Eleni
- dc.contributor.author Darker, Iain
- dc.contributor.author Iotti, Valentina
- dc.contributor.author Slonim, Efrat
- dc.contributor.author de Koning, Harry J.
- dc.contributor.author Alcantara Souza, Rodrigo
- dc.contributor.author Burrion, Jean-Benoit
- dc.contributor.author de Montgolfier, Sandrine
- dc.contributor.author Vissac-Sabatier, Cécile
- dc.contributor.author Guindy, Michal
- dc.contributor.author Pattacini, Pierpaolo
- dc.contributor.author Delaloge, Suzette
- dc.contributor.author Gilbert, Fiona J.
- dc.contributor.author Chen, Yan
- dc.contributor.author MyPeBS Consortium
- dc.date.accessioned 2025-11-12T18:16:34Z
- dc.date.available 2025-11-12T18:16:34Z
- dc.date.issued 2025
- dc.date.updated 2025-11-12T18:16:34Z
- dc.description.abstract Purpose: A survey conducted by the European Society of Breast Imaging (EUSOBI) in 2023 revealed significant variations in Quality Assurance (QA) practices across Europe. The UK encourages regular performance monitoring for screen readers. This study aimed to assess the variability in diagnostic performance among readers participating in a wider prospective randomised trial across multiple countries. Method: In this retrospective multinational study, breast imaging readers from the MyPeBS clinical trial examined a test set of 40 challenging breast screening cases using the PERFORMS software, from March 2021 to February 2022. The challenging set, enriched with biopsy-proven cancers, aimed to differentiate readers by their level of diagnostic performance. Cancer detection and correct return to screen rates were calculated for each participant. Results: A total of 110 readers from 6 countries completed the PERFORMS test set, while 88 also completed an accompanying questionnaire collecting information about their breast screening work and experience. The study revealed variability in cancer detection rates (M = 73.6 %, SD = 19.7 %, range 0.0 %-100.0 %) and correct return to screen rates (M = 79.7 %, SD = 10.5 %, range 46.4 %-100.0 %). Outliers with extremely low cancer detection (2.7 % of participants) and correct return to screen rates (1.8 % of participants) were also identified. Conclusions: Breast imaging readers' performance in test set-based assessments like PERFORMS can reflect real-world screening proficiency. The presence of outlier readers with low diagnostic performance on the test highlights the need for double reading and for standardised QA protocols to ensure patient safety and service efficiency.
- dc.description.sponsorship The current study is funded as part of the MyPeBS clinical trial, which is supported by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 755394. The funders had no role in in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the manuscript for publication.
- dc.format.mimetype application/pdf
- dc.identifier.citation Michalopoulou E, Darker I, Iotti V, Slonim E, de Koning HJ, Souza RA, Burrion JB, De Montgolfier S, Vissac-Sabatier C, Guindy M, Pattacini P, Delaloge S, Gilbert FJ, Chen Y; MyPeBS Consortium. Breast imaging readers' performance in the PERFORMS test-set based assessment scheme within the MyPeBS international randomised study. Eur J Radiol. 2025 Feb;183:111938. DOI: 10.1016/j.ejrad.2025.111938
- dc.identifier.doi http://dx.doi.org/10.1016/j.ejrad.2025.111938
- dc.identifier.issn 0720-048X
- dc.identifier.uri http://hdl.handle.net/10230/71873
- dc.language.iso eng
- dc.publisher Elsevier
- dc.relation.ispartof European Journal of Radiology. 2025;183:111938
- dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/755394
- dc.rights © 2025 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Cancer detection
- dc.subject.keyword Mammography
- dc.subject.keyword Performance
- dc.subject.keyword Quality assurance
- dc.subject.keyword Sensitivity and specificity
- dc.title Breast imaging readers' performance in the PERFORMS test-set based assessment scheme within the MyPeBS international randomised study
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion
